Search Results - "Stunes, Astrid K"

Maximal Strength Training Improves Bone Mineral Density and Neuromuscular Performance in Young Adult Women by Mosti, Mats P, Carlsen, Trude, Aas, Elisabeth, Hoff, Jan, Stunes, Astrid K, Syversen, Unni

“…ABSTRACTMosti, MP, Carlsen, T, Aas, E, Hoff, J, Stunes, AK, and Syversen, U. Maximal strength training improves bone mineral density and neuromuscular…”
Get full text

Do patients with gastroesophageal reflux disease exhibit compromised bone quality prior to proton pump inhibitor therapy? by Aasarød, Kristin M., Mosti, Mats P., Finstad, Malin T., Stunes, Astrid K., Fossmark, Reidar, Syversen, Unni

“…Patients with gastroesophageal reflux disease (GERD) are routinely treated with proton pump inhibitors (PPIs), despite many reports of increased fracture risk…”
Get full text

Decreased bone mineral density and reduced bone quality in H+/K+ATPase beta-subunit deficient mice by Fossmark, Reidar, Stunes, Astrid K., Petzold, Christiane, Waldum, Helge L., Rubert, Marina, Lian, Aina-Mari, Reseland, Janne E., Syversen, Unni

“…Proton pump inhibitors (PPIs) are widely used against gastroesophageal reflux disease. Recent epidemiological studies suggest that PPI users have an increased…”
Get full text

Systemic Leptin Administration in Supraphysiological Doses Maintains Bone Mineral Density and Mechanical Strength Despite Significant Weight Loss by Stunes, Astrid K, Westbroek, Irene, Gordeladze, Jan O, Gustafsson, Björn I, Reseland, Janne E, Syversen, Unni

“…The effects of leptin on bone are controversial. Although in vitro studies have shown that leptin stimulates osteoblast differentiation and mineralization and…”
Get full text

The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats by Stunes, Astrid K, Westbroek, Irene, Gustafsson, Björn I, Fossmark, Reidar, Waarsing, Jan H, Eriksen, Erik F, Petzold, Christiane, Reseland, Janne E, Syversen, Unni

“…Activation of peroxisome proliferator-activated receptor (PPAR)gamma is associated with bone loss and increased fracture risk, while PPARalpha activation seems…”
Get full text

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone by Syversen, Unni, Stunes, Astrid K, Gustafsson, Björn I, Obrant, Karl J, Nordsletten, Lars, Berge, Rolf, Thommesen, Liv, Reseland, Janne E

“…Abstract Background All the peroxisome proliferator activated receptors (PPARs) are found to be expressed in bone cells. The PPARγ agonist rosiglitazone has…”
Get full text

Maximal Strength Training in Postmenopausal Women With Osteoporosis or Osteopenia by Mosti, Mats P., Kaehler, Nils, Stunes, Astrid K., Hoff, Jan, Syversen, Unni

“…ABSTRACTMosti, MP, Kaehler, N, Stunes, AK, Hoff, J, and Syversen, U. Maximal strength training in postmenopausal women with osteoporosis or osteopenia. J…”
Get full text

Body composition in adults born preterm with very low birth weight by Jussinniemi, Laura, Kulmala, Maarit K., Aakvik, Kristina A. D., Benum, Silje D., Jørgensen, Anna P. M., Balasuriya, Chandima N. D., Stunes, Astrid K., Syversen, Unni, Indredavik, Marit S., Andersson, Sture, Hovi, Petteri, Evensen, Kari Anne I., Kajantie, Eero

“…Background Studies on body composition in preterm very low birth weight (VLBW < 1500 g) survivors are inconsistent and trajectories later in life unknown. We…”
Get full text

Serotonin and fluoxetine receptors are expressed in enamel organs and LS8 cells and modulate gene expression in LS8 cells by Riksen, Elisabeth A., Stunes, Astrid K., Kalvik, Anne, Gustafsson, Björn I., Snead, Malcolm L., Syversen, Unni, Lyngstadaas, Ståle P., Reseland, Janne E.

“…Riksen EA, Stunes AK, Kalvik A, Gustafsson BI, Snead ML, Syversen U, Lyngstadaas SP, Reseland JE. Serotonin and fluoxetine receptors are expressed in enamel…”
Get full text

Effects of the Histamine 1 Receptor Antagonist Cetirizine on the Osteoporotic Phenotype in H+/K+ATPase Beta Subunit KO Mice by Aasarød, Kristin M., Stunes, Astrid K., Mosti, Mats P., Ramezanzadehkoldeh, Masoud, Viggaklev, Bjørn I., Reseland, Janne E., Skallerud, Bjørn H., Fossmark, Reidar, Syversen, Unni

“…ABSTRACT Epidemiological studies suggest increased fracture risk in patients using proton pump inhibitors (PPIs). We have previously shown that the H+/K+ATPase…”
Get full text

Skeletal effects of a gastrin receptor antagonist in H+/K+ATPase beta subunit KO mice by Aasarød, Kristin M, Ramezanzadehkoldeh, Masoud, Shabestari, Maziar, Mosti, Mats P, Stunes, Astrid K, Reseland, Janne E, Beisvag, Vidar, Eriksen, Erik Fink, Sandvik, Arne K, Erben, Reinhold G, Schüler, Christiane, Boyce, Malcolm, Skallerud, Bjørn H, Syversen, Unni, Fossmark, Reidar

“…Epidemiological studies suggest an increased fracture risk in patients taking proton pump inhibitors (PPIs) for long term. The underlying mechanism, however,…”
Get full text

The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas by Aune, Guro, Stunes, Astrid K, Tingulstad, Solveig, Salvesen, Oyvind, Syversen, Unni, Torp, Sverre H

“…The identification of new proliferation markers could have clinical implications in ovarian carcinoma by stratifying patients for treatment and follow-up. The…”
Get full text

Mo1082 The Effect of Three Months use of Proton Pump Inhibitors on Bone Mineral Density, Bone Markers and Calcium Metabolism in Men With Gastroesophageal Reflux Disease by Fossmark, Reidar, Teie, Malin I, Stunes, Astrid K, Mosti, Mats P, Viggaklev, Bjorn I, Syversen, Unni

Get full text

Long-term serotonin effects in the rat are prevented by terguride by Hauso, Øyvind, Gustafsson, Björn I., Loennechen, Jan P., Stunes, Astrid K., Nordrum, Ivar, Waldum, Helge L.

“…Long-term hyperserotoninemia induces heart valve disease in rats, and cases of cardiac valvulopathies have been reported in patients using ergolines, possibly…”
Get full text

Enamel matrix derivative stimulates expression and secretion of resistin in mesenchymal cells by Obregon-Whittle, Maria V., Stunes, Astrid K., Almqvist, Sofia, Brookes, Steven J., Lee, James D., Syversen, Unni, Lyngstadaas, Staale P., Reseland, Janne E.

“…Obregon‐Whittle MV, Stunes AK, Almqvist S, Brookes SJ, Lee JD, Syversen U, Lyngstadaas SP, Reseland JE. Enamel matrix derivative stimulates expression and…”
Get full text

495 WITHDRAWN by Fossmark, Reidar, Stunes, Astrid K, Rubert, Marina, Waldum, Helge L, Petzold, Christiane, Lian, Aina-Mari, Reseland, Janne E, Syversen, Unni

Get full text

Sa1332 GASTRIC CORPUS MUCOSAL HYPERPLASIA AND NEUROENDOCRINE CELL HYPERPASIA, BUT NOT SPASMOLYTIC POLYPEPTICE-EXPRESSING METAPLASIA, IS PREVENTED BY A GASTRIN-BLOCKER IN H+/K+ ATPASE BETA SUBUNIT DEFICIENT MICE by Aasarød, Kristin M., Waldum, Helge, Stunes, Astrid K., Sandvik, Arne K., Flatberg, Arnar, Mjønes, Patricia G., Syversen, Unni, Bakke, Ingunn, Fossmark, Reidar

Get full text

Effects of the Histamine 1 Receptor Antagonist Cetirizine on the Osteoporotic Phenotype in H super(+)/K super(+)ATPase Beta Subunit KO Mice by Aasaroed, Kristin M, Stunes, Astrid K, Mosti, Mats P, Ramezanzadehkoldeh, Masoud, Viggaklev, Bjoern I, Reseland, Janne E, Skallerud, Bjoern H, Fossmark, Reidar, Syversen, Unni

“…Epidemiological studies suggest increased fracture risk in patients using proton pump inhibitors (PPIs). We have previously shown that the H super(+)/K…”
Get full text

Heavy, Explosive Strength Training For Postmenopausal Women With Osteoporosis: A Pilot Study by Mosti, Mats P, Kaehler, Nils, Stunes, Astrid K, Hoff, Jan, Syversen, Unni

“…The present study investigated the effects of a heavy, explosive strength training programme on physical capacity, bone mineral density (BMD) and content (BMC)…”
Get full text

Different skeletal effects of the peroxisome proliferator activated receptor [alpha] agonist fenofibrate and the PPAR[gamma] agonist pioglitazone by Syversen, Unni, Stunes, Astrid K, Gustafsson, Björn I, Obrant, Karl J, Nordsletten, Lars, Berge, Rolf, Thommesen, Liv, Reseland, Janne E

“…Background All the peroxisome proliferator activated receptors (PPARs) are found to be expressed in bone cells. The PPAR[gamma] agonist rosiglitazone has been…”
Get full text